Key statistics
As of last trade Hofseth Biocare ASA (HBC:OSL) traded at 1.71, 0.29% above its 52-week low of 1.70, set on Sep 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.78 |
---|---|
High | 1.79 |
Low | 1.71 |
Bid | 1.70 |
Offer | 1.71 |
Previous close | 1.78 |
Average volume | 76.19k |
---|---|
Shares outstanding | 395.08m |
Free float | 169.50m |
P/E (TTM) | -- |
Market cap | 673.61m NOK |
EPS (TTM) | -0.3023 NOK |
Data delayed at least 15 minutes, as of Sep 19 2024.
More ▼
- Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT
- Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY
- Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc.
- Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY
- Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT
- Hofseth Biocare ASA: Annual General Meeting completed
- Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024
- Hofseth Biocare ASA: HBC ANNUAL REPORT 2023
- Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING
- Hofseth Biocare ASA: UPDATED COMPANY PRESENTATION
More ▼